Horseracing Integrity and Safety Act of 2020

The Horseracing Integrity and Safety Act of 2020 (HR1754) establishes a national anti-doping and medication control program and uniform safety standards for horseracing. This legislation creates a single, independent authority to oversee these aspects, replacing the fragmented state-by-state regulatory system. This standardization reduces regulatory arbitrage and enhances the integrity of the sport, which directly impacts the betting market and the breeding industry. The money trail for this legislation is indirect. The Act does not appropriate federal funds but mandates the horseracing industry to fund the new authority. This means increased operational costs for racetracks and horse owners, which will be passed on through fees. Companies involved in racing operations, such as Churchill Downs Inc. ($CDNA), Penn Entertainment ($PENN), and MGM Resorts International ($MGM) through their racing and betting interests, will incur these new costs. The enhanced integrity could, however, attract more betting volume to platforms like DraftKings ($DKNG) and FanDuel (owned by Flutter Entertainment, not publicly traded in the US as a primary listing). Historically, similar federal interventions in sports regulation are rare. However, state-level crackdowns on doping have shown mixed results. For example, when New York implemented stricter drug testing protocols in 2012, racing handle initially saw a slight dip due to reduced entries but stabilized as integrity improved. No direct federal precedent exists for a market-wide impact on publicly traded entities in the horseracing sector. Specific winners include companies that benefit from increased betting integrity, such as online sports betting platforms like DraftKings ($DKNG) if the sport gains broader appeal due to enhanced trust. Losers are primarily the racetracks and horse owners who will bear the direct costs of funding the new authority and complying with stricter regulations. This includes companies like Churchill Downs Inc. ($CDNA), Penn Entertainment ($PENN), and MGM Resorts International ($MGM) which operate significant racing assets. The breeding industry, represented by companies like The Stronach Group (private), will also face increased compliance costs. This bill was received in the Senate on September 30, 2020. It became law in December 2020. The implementation of the Act began in phases, with the anti-doping and medication control program becoming fully effective in May 2023. The market has already absorbed the initial impact of this legislation becoming law. Future impacts will be incremental as the new authority refines its operations and enforcement.